Literature DB >> 32758561

The PERT Concept: A Step-by-Step Approach to Managing Pulmonary Embolism.

Belinda N Rivera-Lebron1, Parth M Rali2, Victor F Tapson3.   

Abstract

Pulmonary embolism (PE) is a major source of morbidity and mortality. The presentation of acute PE varies, ranging from few or no symptoms to sudden death. Patient outcome depends on how well the right ventricle can sustain the increased afterload caused by the embolic burden. Careful risk stratification is critical, and the PE response team (PERT) concept offers a rapid and multidisciplinary approach. Anticoagulation is essential unless contraindicated; thrombolysis, surgical embolectomy, and catheter-directed approaches are also available. Clinical consensus statements have been published that offer a guide to PE management, but areas remain for which the evidence is inadequate. Although the management of low-risk and high-risk patients is more straightforward, optimal management of intermediate-risk patients remains controversial. In this document, we offer a case-based approach to PE management, beginning with diagnosis and risk stratification, followed by therapeutic alternatives, and finishing with follow-up care.
Copyright © 2020 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  acute pulmonary embolism; chronic thromboembolic pulmonary disease; chronic thromboembolic pulmonary hypertension; pulmonary embolism response team

Year:  2020        PMID: 32758561     DOI: 10.1016/j.chest.2020.07.065

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  3 in total

1.  Autophagy genes CCL2 and MYC are considered as potential biomarkers for pulmonary embolism.

Authors:  Xuehui Zhang; Naibin Yang; Lijiang Shao; Xuxia Chen; Xueqin Chen
Journal:  Am J Transl Res       Date:  2022-08-15       Impact factor: 3.940

2.  Communication at diagnosis of venous thromboembolism: Lasting impact of verbal and nonverbal provider communication on patients.

Authors:  Jackeline Hernandez-Nino; Mary Thomas; Andreia B Alexander; Mary A Ott; Jeffrey A Kline
Journal:  Res Pract Thromb Haemost       Date:  2022-01-15

3.  Safety and outcomes of thrombolytic therapy in patients with pulmonary embolism and thrombocytopenia: A systematic review.

Authors:  Fateen Ata; Wanis Hamad Ibrahim; Mohammad Nasser Affas; Haseeb Ahmad Khan; Hafiz Waqas Younas; Zakaria Maat; Sabah Elshayeb Ali Mohamed; Balqis Daoudi
Journal:  Qatar Med J       Date:  2022-08-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.